Digene Aktie - DIGE

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

QIAGEN Announces Completion of Digene Acquisition

VENLO, The Netherlands, July 30 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) announced today the...

HealthShares(TM) Announces Change to the HealthShares(TM) Diagnostics Index

NEW YORK, July 27 /PRNewswire/ -- HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today announced...

QIAGEN Completes Exchange Offer for Digene Corporation

Anticipates Prompt Completion of Acquisition VENLO, Netherlands, July 26 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime...

Digene Enters Four-Year HPV Testing Contract with Quest Diagnostics

GAITHERSBURG, Md., July 25 /PRNewswire-FirstCall/ -- Digene Corp. (NASDAQ:DIGE) will continue to supply Quest Diagnostics' (NYSE:DGX) network of...

Claim Construction Decision Issued in Digene's Patent Litigation With Third Wave Technologies

GAITHERSBURG, Md., July 24 /PRNewswire-FirstCall/ -- Digene Corp. (NASDAQ:DIGE) announced that the U.S. District Court for the Western District...

Standard & Poor's Announces Changes to U.S. Indices

NEW YORK, July 23 /PRNewswire/ -- Standard & Poor's will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices:...

Court Dismisses Gen-Probe Court Action Against Digene

GAITHERSBURG, Md., July 23 /PRNewswire-FirstCall/ -- Digene Corp. (NASDAQ:DIGE) today announced that a California state court has dismissed a...

QIAGEN and Digene Announce Expiration of Hart-Scott-Rodino Waiting Period

VENLO, Netherlands and GAITHERSBURG, Md, July 17 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) and Digene...

Gen-Probe Authorized To Join Digene-Roche Arbitration Proceeding

GAITHERSBURG, Md., July 16 /PRNewswire-FirstCall/ -- Digene Corp. (NASDAQ:DIGE) today announced that on July 13, the panel hearing the...

Global Summit of Women Launches Consortium to End Cervical Cancer

Focus to Include Education on Both HPV Testing and Vaccination GAITHERSBURG, Md., June 21 /PRNewswire/ -- The Global Summit of Women concluded...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

DIGE - Frequently Asked Questions (FAQ)

What is the current Digene share price?

The current share price of Digene is US$ 0,00

What is the 1 year trading range for Digene share price?

Digene has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
MSGMMotorsport Games Inc	US$ 2,69 (140,18%)	37M
SXTCChina SXT Pharmaceuticals Inc	US$ 2,11 (113,37%)	51,73M
ADGMAdagio Medical Holdings Inc	US$ 1,68 (81,98%)	115,48M
PNBKPatriot National Bancorp Inc	US$ 3,28 (73,54%)	1,57M
RTCBaijiayun Group Ltd	US$ 0,3601 (67,49%)	187,02M
LXEHLixiang Education Holding Company Ltd	US$ 8,25 (-64,11%)	1,55M
CLIKClick Holdings Ltd	US$ 0,355 (-48,18%)	13,52M
IOTRiOThree Ltd	US$ 1,1409 (-38,33%)	3,93M
FMTOFemto Technologies Inc	US$ 0,0191 (-35,47%)	198,4M
SISIShineco Inc	US$ 0,5809 (-35,07%)	824,91k
DMNDamon Inc	US$ 0,0034 (9,68%)	409,39M
STSSSharps Technology Inc	US$ 0,03195 (20,57%)	391,8M
SUNESUNation Energy Inc	US$ 0,0176 (-10,20%)	349,4M
NVDANVIDIA Corporation	US$ 101,49 (-2,87%)	292,48M
HTZHertz Global Holdings Inc	US$ 8,205 (43,70%)	266,91M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Digene Corp (MM) (DIGE)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

DIGE Neueste Nachrichten

QIAGEN Announces Completion of Digene Acquisition

HealthShares(TM) Announces Change to the HealthShares(TM) Diagnostics Index

QIAGEN Completes Exchange Offer for Digene Corporation

Digene Enters Four-Year HPV Testing Contract with Quest Diagnostics

Claim Construction Decision Issued in Digene's Patent Litigation With Third Wave Technologies

Standard & Poor's Announces Changes to U.S. Indices

Court Dismisses Gen-Probe Court Action Against Digene

QIAGEN and Digene Announce Expiration of Hart-Scott-Rodino Waiting Period

Gen-Probe Authorized To Join Digene-Roche Arbitration Proceeding

Global Summit of Women Launches Consortium to End Cervical Cancer

DIGE - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Digene Corp (MM) (DIGE) Börsenkurse

Digene Corp (MM) (DIGE)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

DIGE Neueste Nachrichten

QIAGEN Announces Completion of Digene Acquisition

HealthShares(TM) Announces Change to the HealthShares(TM) Diagnostics Index

QIAGEN Completes Exchange Offer for Digene Corporation

Digene Enters Four-Year HPV Testing Contract with Quest Diagnostics

Claim Construction Decision Issued in Digene's Patent Litigation With Third Wave Technologies

Standard & Poor's Announces Changes to U.S. Indices

Court Dismisses Gen-Probe Court Action Against Digene

QIAGEN and Digene Announce Expiration of Hart-Scott-Rodino Waiting Period

Gen-Probe Authorized To Join Digene-Roche Arbitration Proceeding

Global Summit of Women Launches Consortium to End Cervical Cancer

DIGE - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS